130 related articles for article (PubMed ID: 9468023)
1. Effect of administration route and dose of streptavidin or biotin on the tumor uptake of radioactivity in intraperitoneal tumor with multistep targeting.
Zhang M; Yao Z; Sakahara H; Saga T; Nakamoto Y; Sato N; Zhao S; Nakada H; Yamashina I; Konishi J
Nucl Med Biol; 1998 Feb; 25(2):101-5. PubMed ID: 9468023
[TBL] [Abstract][Full Text] [Related]
2. Improved intratumoral penetration of radiolabeled streptavidin in intraperitoneal tumors pretargeted with biotinylated antibody.
Zhang M; Yao Z; Saga T; Sakahara H; Nakamoto Y; Sato N; Nakada H; Yamashina I; Konishi J
J Nucl Med; 1998 Jan; 39(1):30-3. PubMed ID: 9443734
[TBL] [Abstract][Full Text] [Related]
3. Intravenous avidin chase improved localization of radiolabeled streptavidin in intraperitoneal xenograft pretargeted with biotinylated antibody.
Zhang M; Sakahara H; Yao Z; Saga T; Nakamoto Y; Sato N; Nakada H; Yamashina I; Konishi J
Nucl Med Biol; 1997 Jan; 24(1):61-4. PubMed ID: 9080476
[TBL] [Abstract][Full Text] [Related]
4. Three-step tumor imaging with biotinylated monoclonal antibody, streptavidin and 111In-DTPA-biotin.
Nakamoto Y; Saga T; Sakahara H; Yao Z; Zhang M; Sato N; Zhao S; Nakada H; Yamashina I; Konishi J
Nucl Med Biol; 1998 Feb; 25(2):95-9. PubMed ID: 9468022
[TBL] [Abstract][Full Text] [Related]
5. Pretargeted radioimmunotherapy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal dose.
Förster GJ; Santos EB; Smith-Jones PM; Zanzonico P; Larson SM
J Nucl Med; 2006 Jan; 47(1):140-9. PubMed ID: 16391198
[TBL] [Abstract][Full Text] [Related]
6. Improved targeting of radiolabeled streptavidin in tumors pretargeted with biotinylated monoclonal antibodies through an avidin chase.
Yao Z; Zhang M; Kobayashi H; Sakahara H; Nakada H; Yamashina I; Konishi J
J Nucl Med; 1995 May; 36(5):837-41. PubMed ID: 7738661
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunotherapy of A431 xenografted mice with pretargeted B3 antibody-streptavidin and (90)Y-labeled 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-biotin.
Yao Z; Zhang M; Axworthy DB; Wong KJ; Garmestani K; Park L; Park CW; Mallett RW; Theodore LJ; Yau EK; Waldmann TA; Brechbiel MW; Paik CH; Pastan I; Carrasquillo JA
Cancer Res; 2002 Oct; 62(20):5755-60. PubMed ID: 12384535
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal radio-localization of tumors pre-targeted by biotinylated monoclonal antibodies.
Paganelli G; Pervez S; Siccardi AG; Rowlinson G; Deleide G; Chiolerio F; Malcovati M; Scassellati GA; Epenetos AA
Int J Cancer; 1990 Jun; 45(6):1184-9. PubMed ID: 2351490
[TBL] [Abstract][Full Text] [Related]
9. Increased streptavidin uptake in tumors pretargeted with biotinylated antibody using a conjugate of streptavidin-fab fragment.
Yao Z; Zhang M; Sakahara H; Saga T; Kobayashi H; Nakamoto Y; Toyama S; Konishi J
Nucl Med Biol; 1998 Aug; 25(6):557-60. PubMed ID: 9751423
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
Buchsbaum DJ; Khazaeli MB; Axworthy DB; Schultz J; Chaudhuri TR; Zinn KR; Carpenter M; LoBuglio AF
Clin Cancer Res; 2005 Nov; 11(22):8180-5. PubMed ID: 16299250
[TBL] [Abstract][Full Text] [Related]
11. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model.
Sharkey RM; Karacay H; Griffiths GL; Behr TM; Blumenthal RD; Mattes MJ; Hansen HJ; Goldenberg DM
Bioconjug Chem; 1997; 8(4):595-604. PubMed ID: 9258460
[TBL] [Abstract][Full Text] [Related]
12. Antibody-dependent signal amplification in tumor xenografts after pretreatment with biotinylated monoclonal antibody and avidin or streptavidin.
Kassis AI; Jones PL; Matalka KZ; Adelstein SJ
J Nucl Med; 1996 Feb; 37(2):343-52. PubMed ID: 8667075
[TBL] [Abstract][Full Text] [Related]
13. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
Lewis MR; Wang M; Axworthy DB; Theodore LJ; Mallet RW; Fritzberg AR; Welch MJ; Anderson CJ
J Nucl Med; 2003 Aug; 44(8):1284-92. PubMed ID: 12902420
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the chase effects of avidin, streptavidin, neutravidin, and avidin-ferritin on a radiolabeled biotinylated anti-tumor monoclonal antibody.
Kobayashi H; Sakahara H; Endo K; Hosono M; Yao ZS; Toyama S; Konishi J
Jpn J Cancer Res; 1995 Mar; 86(3):310-4. PubMed ID: 7744702
[TBL] [Abstract][Full Text] [Related]
15. PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V.
Cauchon N; Langlois R; Rousseau JA; Tessier G; Cadorette J; Lecomte R; Hunting DJ; Pavan RA; Zeisler SK; van Lier JE
Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):247-58. PubMed ID: 17021816
[TBL] [Abstract][Full Text] [Related]
16. Pretargeted radioimmunotherapy of mesothelin-expressing cancer using a tetravalent single-chain Fv-streptavidin fusion protein.
Sato N; Hassan R; Axworthy DB; Wong KJ; Yu S; Theodore LJ; Lin Y; Park L; Brechbiel MW; Pastan I; Paik CH; Carrasquillo JA
J Nucl Med; 2005 Jul; 46(7):1201-9. PubMed ID: 16000290
[TBL] [Abstract][Full Text] [Related]
17. Improved tumor targeting and decreased normal tissue accumulation through extracorporeal affinity adsorption in a two-step pretargeting strategy.
Mårtensson L; Nilsson R; Ohlsson T; Sjögren HO; Strand SE; Tennvall J
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5572s-5576s. PubMed ID: 17875791
[TBL] [Abstract][Full Text] [Related]
18. Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2.
Cheung NK; Modak S; Lin Y; Guo H; Zanzonico P; Chung J; Zuo Y; Sanderson J; Wilbert S; Theodore LJ; Axworthy DB; Larson SM
J Nucl Med; 2004 May; 45(5):867-77. PubMed ID: 15136638
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
